A novel multi-drug metronomic chemotherapy significantly delays tumor growth in mice
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A novel multi-drug metronomic chemotherapy significantly delays tumor growth in mice
Authors
Keywords
Immunotherapy, Daily metronomic chemotherapy, Treg
Journal
Journal of Translational Medicine
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-02-24
DOI
10.1186/s12967-016-0812-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Novel metronomic chemotherapy and cancer vaccine combinatorial strategy for hepatocellular carcinoma in a mouse model
- (2015) Maria Tagliamonte et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Metronomic chemotherapy: An attractive alternative to maximum tolerated dose therapy that can activate anti-tumor immunity and minimize therapeutic resistance
- (2015) Irina Kareva et al. CANCER LETTERS
- An Increased Abundance of Tumor-Infiltrating Regulatory T Cells Is Correlated with the Progression and Prognosis of Pancreatic Ductal Adenocarcinoma
- (2014) Yichen Tang et al. PLoS One
- Increased Risk of Serious Non-AIDS-Related Events in HIV-Infected Subjects on Antiretroviral Therapy Associated with a Low CD4/CD8 Ratio
- (2014) Sergio Serrano-Villar et al. PLoS One
- Chemotherapy Acts as an Adjuvant to Convert the Tumor Microenvironment into a Highly Permissive State for Vaccination-Induced Antitumor Immunity
- (2013) T. H. Kang et al. CANCER RESEARCH
- Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer
- (2013) L Bracci et al. CELL DEATH AND DIFFERENTIATION
- Myeloid derived suppressor cells in physiological and pathological conditions: the good, the bad, and the ugly
- (2013) Paolo Serafini IMMUNOLOGIC RESEARCH
- Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer
- (2013) Je-In Youn et al. NATURE IMMUNOLOGY
- Low-dose cyclophosphamide administered as daily or single dose enhances the antitumor effects of a therapeutic HPV vaccine
- (2012) Shiwen Peng et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor-Infiltrating Monocytic Myeloid-Derived Suppressor Cells Mediate CCR5-Dependent Recruitment of Regulatory T Cells Favoring Tumor Growth
- (2012) E. Schlecker et al. JOURNAL OF IMMUNOLOGY
- Targeted inhibition of IL-10-secreting CD25−Tregviap38 MAPK suppression in cancer immunotherapy
- (2010) Kozo Ohkusu-Tsukada et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- A comparison of low-dose cyclophosphamide treatment with artemisinin treatment in reducing the number of regulatory T cells in murine breast cancer model
- (2010) Ladan Langroudi et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Circulating regulatory T cells (CD4+CD25+FOXP3+) decrease in breast cancer patients after vaccination with a modified MHC class II HER2/neu (AE37) peptide
- (2010) Jeremy D. Gates et al. VACCINE
- Myeloid Cells in the Tumor Microenvironment: Modulation of Tumor Angiogenesis and Tumor Inflammation
- (2010) Michael C. Schmid et al. Journal of Oncology
- Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responses
- (2009) W M Liu et al. BRITISH JOURNAL OF CANCER
- Cyclophosphamide Augments Antitumor Immunity: Studies in an Autochthonous Prostate Cancer Model
- (2009) S. Wada et al. CANCER RESEARCH
- Immunoregulatory T cells in the peripheral blood of melanoma patients treated with melanoma antigen-pulsed mature monocyte-derived dendritic cell vaccination
- (2009) Noriaki Nakai et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitro
- (2008) X. Feng et al. BLOOD
- Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy
- (2008) C. Marcela Diaz-Montero et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Combination of Docetaxel and Recombinant Vaccine Enhances T-Cell Responses and Antitumor Activity: Effects of Docetaxel on Immune Enhancement
- (2008) C. T. Garnett et al. CLINICAL CANCER RESEARCH
- A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma
- (2008) Daniel H. Palmer et al. HEPATOLOGY
- Dendritic Cell Vaccination Induces Tumor Epitope-specific Th1 Immune Response in Medullary Thyroid Carcinoma
- (2008) C. Papewalis et al. HORMONE AND METABOLIC RESEARCH
- Therapeutic Vaccination Halts Disease Progression in BALB-neuT Mice: The Amplitude of Elicited Immune Response Is Predictive of Vaccine Efficacy
- (2008) Barbara Cipriani et al. HUMAN GENE THERAPY
- Vaccination of B-CLL patients with autologous dendritic cells can change the frequency of leukemia antigen-specific CD8+ T cells as well as CD4+CD25+FoxP3+ regulatory T cells toward an antileukemia response
- (2008) I Hus et al. LEUKEMIA
- CTLA-4 Control over Foxp3+ Regulatory T Cell Function
- (2008) K. Wing et al. SCIENCE
- Differential effects of age on circulating and splenic leukocyte populations in C57BL/6 and BALB/c male mice
- (2008) Lesya M Pinchuk et al. Immunity & Ageing
- Dose translation from animal to human studies revisited
- (2007) Shannon Reagan-Shaw et al. FASEB JOURNAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now